353 related articles for article (PubMed ID: 15652970)
1. Inhibition of SARS-CoV replication by siRNA.
Wu CJ; Huang HW; Liu CY; Hong CF; Chan YL
Antiviral Res; 2005 Jan; 65(1):45-8. PubMed ID: 15652970
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of severe acute respiratory syndrome virus replication by small interfering RNAs in mammalian cells.
Wang Z; Ren L; Zhao X; Hung T; Meng A; Wang J; Chen YG
J Virol; 2004 Jul; 78(14):7523-7. PubMed ID: 15220426
[TBL] [Abstract][Full Text] [Related]
3. siRNA targeting the leader sequence of SARS-CoV inhibits virus replication.
Li T; Zhang Y; Fu L; Yu C; Li X; Li Y; Zhang X; Rong Z; Wang Y; Ning H; Liang R; Chen W; Babiuk LA; Chang Z
Gene Ther; 2005 May; 12(9):751-61. PubMed ID: 15772689
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of replication and infection of severe acute respiratory syndrome-associated coronavirus with plasmid-mediated interference RNA.
Ni B; Shi X; Li Y; Gao W; Wang X; Wu Y
Antivir Ther; 2005; 10(4):527-33. PubMed ID: 16038478
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SARS-CoV-2 Replication by a Small Interfering RNA Targeting the Leader Sequence.
Tolksdorf B; Nie C; Niemeyer D; Röhrs V; Berg J; Lauster D; Adler JM; Haag R; Trimpert J; Kaufer B; Drosten C; Kurreck J
Viruses; 2021 Oct; 13(10):. PubMed ID: 34696460
[TBL] [Abstract][Full Text] [Related]
6. siRNA silencing of angiotensin-converting enzyme 2 reduced severe acute respiratory syndrome-associated coronavirus replications in Vero E6 cells.
Lu CY; Huang HY; Yang TH; Chang LY; Lee CY; Huang LM
Eur J Clin Microbiol Infect Dis; 2008 Aug; 27(8):709-15. PubMed ID: 18449585
[TBL] [Abstract][Full Text] [Related]
7. SARS coronavirus and apoptosis.
Chow KY; Yeung YS; Hon CC; Zeng F; Law KM; Leung FC
Hong Kong Med J; 2008 Aug; 14 Suppl 4():8-13. PubMed ID: 18708667
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of SARS-CoV replication cycle by small interference RNAs silencing specific SARS proteins, 7a/7b, 3a/3b and S.
Akerström S; Mirazimi A; Tan YJ
Antiviral Res; 2007 Mar; 73(3):219-27. PubMed ID: 17112601
[TBL] [Abstract][Full Text] [Related]
9. Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells.
Qin ZL; Zhao P; Zhang XL; Yu JG; Cao MM; Zhao LJ; Luan J; Qi ZT
Biochem Biophys Res Commun; 2004 Nov; 324(4):1186-93. PubMed ID: 15504339
[TBL] [Abstract][Full Text] [Related]
10. Dual effect of nitric oxide on SARS-CoV replication: viral RNA production and palmitoylation of the S protein are affected.
Akerström S; Gunalan V; Keng CT; Tan YJ; Mirazimi A
Virology; 2009 Dec; 395(1):1-9. PubMed ID: 19800091
[TBL] [Abstract][Full Text] [Related]
11. Silencing SARS-CoV Spike protein expression in cultured cells by RNA interference.
Zhang Y; Li T; Fu L; Yu C; Li Y; Xu X; Wang Y; Ning H; Zhang S; Chen W; Babiuk LA; Chang Z
FEBS Lett; 2004 Feb; 560(1-3):141-6. PubMed ID: 14988013
[TBL] [Abstract][Full Text] [Related]
12. Inhibiting severe acute respiratory syndrome-associated coronavirus by small interfering RNA.
Zhang R; Guo Z; Lu J; Meng J; Zhou C; Zhan X; Huang B; Yu X; Huang M; Pan X; Ling W; Chen X; Wan Z; Zheng H; Yan X; Wang Y; Ran Y; Liu X; Ma J; Wang C; Zhang B
Chin Med J (Engl); 2003 Aug; 116(8):1262-4. PubMed ID: 12935424
[TBL] [Abstract][Full Text] [Related]
13. The intracellular sites of early replication and budding of SARS-coronavirus.
Stertz S; Reichelt M; Spiegel M; Kuri T; Martínez-Sobrido L; García-Sastre A; Weber F; Kochs G
Virology; 2007 May; 361(2):304-15. PubMed ID: 17210170
[TBL] [Abstract][Full Text] [Related]
14. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein.
Fukushi S; Mizutani T; Saijo M; Matsuyama S; Miyajima N; Taguchi F; Itamura S; Kurane I; Morikawa S
J Gen Virol; 2005 Aug; 86(Pt 8):2269-2274. PubMed ID: 16033974
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of severe acute respiratory syndrome coronavirus replication in a lethal SARS-CoV BALB/c mouse model by stinging nettle lectin, Urtica dioica agglutinin.
Kumaki Y; Wandersee MK; Smith AJ; Zhou Y; Simmons G; Nelson NM; Bailey KW; Vest ZG; Li JK; Chan PK; Smee DF; Barnard DL
Antiviral Res; 2011 Apr; 90(1):22-32. PubMed ID: 21338626
[TBL] [Abstract][Full Text] [Related]
16. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
[TBL] [Abstract][Full Text] [Related]
17. Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice.
Becker MM; Graham RL; Donaldson EF; Rockx B; Sims AC; Sheahan T; Pickles RJ; Corti D; Johnston RE; Baric RS; Denison MR
Proc Natl Acad Sci U S A; 2008 Dec; 105(50):19944-9. PubMed ID: 19036930
[TBL] [Abstract][Full Text] [Related]
18. Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor.
Babcock GJ; Esshaki DJ; Thomas WD; Ambrosino DM
J Virol; 2004 May; 78(9):4552-60. PubMed ID: 15078936
[TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides.
Bosch BJ; Martina BE; Van Der Zee R; Lepault J; Haijema BJ; Versluis C; Heck AJ; De Groot R; Osterhaus AD; Rottier PJ
Proc Natl Acad Sci U S A; 2004 Jun; 101(22):8455-60. PubMed ID: 15150417
[TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome coronavirus replication is severely impaired by MG132 due to proteasome-independent inhibition of M-calpain.
Schneider M; Ackermann K; Stuart M; Wex C; Protzer U; Schätzl HM; Gilch S
J Virol; 2012 Sep; 86(18):10112-22. PubMed ID: 22787216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
